• Amgen

    Helping More Patients. Faster. How Amgen Personalizes Care with Master Data Driven Insights.

  • IQVIA

    IQVIA gained enhanced data accuracy, timeliness, and completeness and faster time to market for its pharmaceuticals

  • Big Data for the Pharmaceutical Industry

    If pharmaceutical companies cannot reduce data management overhead they risk drowning in excessive data. The paper discusses how Life Science companies that wish to be competitive in a world that is rapidly expanding ‘beyond the pill’ can implement capabilities to quickly find relevant data to inform new initiatives or power new solutions and business models.

  • Boost Scientific Efficiency through AI assisted data search and prep

    Pharmaceutical companies continue to invest in several different strategies to increase R&D returns and scientific efficiency. Strategies range from increasing access to research through partnerships or acquisitions, improved execution during clinical trials and patient outreach, and incorporating real world evidence. Despite varied approaches, all strategies have a common thread: access to more data which is generated, stored and analysed in a variety of new and different methods.However, improvements in scientific efficiency will not be boosted by securing access to a larger set of data alone. Scientists and researchers must be provided with the capability to navigate through increasing amounts of available data to find, understand and prepare relevant data to boost discovery and understanding.Find out how Informatica is leveraging artificial intelligence to help research professionals increase their efficiency by:•Reducing time required to search for and prepare data for ...

  • Can IDMP Teams Relax Now?

    All indications point to the IDMP compliance deadline being delayed in the EU. Can we all relax unitl next year, or should the compliance efforts continue?